JPRN-UMIN000001647已完成未知
A prospective study of Trimethoprime-sulfamethoxazole(TMP/SMX) for prevention of Pneumocystis pneumonia(PCP) in patients under immunosuppressive therapy - Prevention study for PCP by TMP/SMX
Division of Rheumatology,Department of Internal Medicine,Toho University School of Mdicine,Tokyo,Japan0 个研究点目标入组 60 人开始时间: 2009年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.On TMP/SMX 2.Suffering from PCP 3.Complicated with serious liver and/or renal disfunction,cytopenia 4.Allergy to TMP/SMX 5.Pregnant,and/or nursing 6.In approppriate patients decided by doctors
研究者
相似试验
已完成
2 期
A study of role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatmentTrimethoprim-sulfamethoxazole primary prophylaxis in lupus patients taking low-level immunosuppressive treatmentLupusTrimethoprim-sulfamethoxazolePneumocystis pneumoniaSystemic lupus erythematosusTCTR20230606002Mahidol university138
已完成
4 期
The effects of trimethoprim-sulfamethoxazole on the pharmacokinetic parameters of mycophenolate mofetil in healthy volunteersHealthyHealthy volunteersTCTR20200518005Faculty of Medicine, Chiang Mai University16
已完成
不适用
Cotrimoxazol to prevent malaria in HIV-infected pregnant women in Sub-Saharan AfricaISRCTN98835811AlterSanté (France)300
已完成
3 期
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular ToxoplasmosisOcular ToxoplasmosisNCT01449877University of Campinas, Brazil141
已完成
不适用
Optimal regimens of sulfamethoxazole-trimethoprim for prophylaxis of pneumocystis pneumonia in patients with systemic rheumatic diseases: multi-center randomized open label trialPneumocystis pneumoniaJPRN-UMIN000031513Juntendo University School of Medicin89